Abstract
The application of antibodies as therapeutic agents in the treatment of cancer now represents a significant proportion of the oncology drug arena. Despite this success, the ability to engineer and exploit antibodies in many different formats is ensuring that new avenues for their therapeutic application are constantly being examined. This review examines a selection of novel antibody-based therapeutic strategies that are currently in late preclinical and clinical evaluation.
| Original language | English |
|---|---|
| Pages (from-to) | 73-86 |
| Number of pages | 14 |
| Journal | Future Medicinal Chemistry |
| Volume | 4 |
| Issue number | 1 |
| Early online date | 15 Dec 2011 |
| DOIs | |
| Publication status | Published - Jan 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Drug Discovery
- Pharmacology
- Molecular Medicine
Fingerprint
Dive into the research topics of 'Recent advances in the application of antibodies as therapeutics.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver